Former US FDA Commissioner on Light Sciences Oncology board
This article was originally published in Clinica
Executive Summary
Light Sciences Oncology (Washington, US), a company that has developed a light-activated device to enable drug treatment for solid tumours among other conditions, has appointed former US FDA Commissioner Frank Young to its board of directors – a newly created seat. Dr Young, whose internship and residency was in pathology, is currently a partner at Essex Woodlands Health Ventures, which is an investor in the company. Other senior positions held by Dr Young include US Representative to the executive committee of the World Health Organization, and dean of the school of medicine and dentistry and vice-president of health affairs at the University of Rochester in New York.